Prescription and Over-the-Counter Drug Product List 40TH EDITION Cumulative Supplement Number 09 : September 2020 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ACETAMINOPHEN AND CAFFEINE >A> AA STRIDES PHARMA 325MG;50MG;40MG A 203647 001 Sep 21, 2020 Sep NEWA ACETAMINOPHEN; CODEINE PHOSPHATE SOLUTION;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >D> AA WOCKHARDT BIO AG 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC >A> @ 120MG/5ML;12MG/5ML A 087006 001 Jul 22, 1981 Sep DISC TABLET;ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE >A> AA NOSTRUM LABS INC 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >A> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >A> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN >D> AA TEVA 300MG;15MG A 088627 001 Mar 06, 1985 Sep CAHN >D> AA 300MG;30MG A 088628 001 Mar 06, 1985 Sep CAHN >D> AA ! 300MG;60MG A 088629 001 Mar 06, 1985 Sep CAHN ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET;ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >A> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >A> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN >D> AA VINTAGE PHARMS 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >A> @ 300MG;5MG A 090415 001 Jan 24, 2011 Sep DISC >D> AA 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >A> @ 300MG;7.5MG A 090415 002 Jan 24, 2011 Sep DISC >D> AA 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >A> @ 300MG;10MG A 090415 003 Jan 24, 2011 Sep DISC >D> @ XIROMED 325MG;5MG A 211690 001 Feb 07, 2020 Sep CAHN >D> @ 325MG;7.5MG A 211690 002 Feb 07, 2020 Sep CAHN >D> @ 325MG;10MG A 211690 003 Feb 07, 2020 Sep CAHN ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET;ORAL OXYCODONE AND ACETAMINOPHEN >A> @ CEROVENE INC 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN >D> @ XIROMED 325MG;5MG A 207574 001 Dec 13, 2016 Sep CAHN ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >A> AB MICRO LABS LTD INDIA 500MG A 207401 001 Oct 01, 2020 Sep NEWA TABLET;ORAL ACETAZOLAMIDE >A> MANKIND PHARMA 125MG A 214282 001 Oct 07, 2020 Sep NEWA >A> 250MG A 214282 002 Oct 07, 2020 Sep NEWA ACYCLOVIR CAPSULE;ORAL ACYCLOVIR >A> AB YILING 200MG A 212173 001 Sep 14, 2020 Sep NEWA OINTMENT;TOPICAL ACYCLOVIR >A> AB ANDA REPOSITORY 5% A 206437 001 Jul 31, 2017 Sep CAHN >D> AB TOLMAR 5% A 206437 001 Jul 31, 2017 Sep CAHN ALBUTEROL SULFATE AEROSOL, METERED;INHALATION ALBUTEROL SULFATE >A> AB2 LUPIN EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN >D> AB2 LUPIN ATLANTIS EQ 0.09MG BASE/INH A 209954 001 Aug 24, 2020 Sep CAHN Page 1 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST AMANTADINE HYDROCHLORIDE CAPSULE;ORAL AMANTADINE HYDROCHLORIDE >D> AB INVATECH 100MG A 210129 001 Mar 02, 2020 Sep CAHN >A> AB NOVELGENIX THERAPS 100MG A 210129 001 Mar 02, 2020 Sep CAHN TABLET, EXTENDED RELEASE;ORAL OSMOLEX ER >D> + OSMOTICA PHARM EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC >A> + @ EQ 161MG BASE N 209410 004 Apr 22, 2020 Sep DISC TABLET;ORAL AMANTADINE HYDROCHLORIDE >D> AB INVATECH 100MG A 210215 001 Mar 10, 2020 Sep CAHN >A> AB NOVELGENIX THERAPS 100MG A 210215 001 Mar 10, 2020 Sep CAHN AMILORIDE HYDROCHLORIDE TABLET;ORAL AMILORIDE HYDROCHLORIDE >A> AB ANDA REPOSITORY 5MG A 204180 001 Aug 07, 2015 Sep CAHN >D> AB WINDLAS HLTHCARE 5MG A 204180 001 Aug 07, 2015 Sep CAHN AMISULPRIDE SOLUTION;INTRAVENOUS BARHEMSYS >A> +! ACACIA 10MG/4ML (2.5MG/ML) N 209510 002 Sep 01, 2020 Sep NEWA AMLODIPINE BESYLATE TABLET;ORAL AMLODIPINE BESYLATE >D> AB HEBEI CHANGSHAN EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >D> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >D> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN >D> AB HIKMA PHARMS EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >A> @ EQ 2.5MG BASE A 077771 001 Apr 12, 2011 Sep DISC >D> AB EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >A> @ EQ 5MG BASE A 077771 002 Apr 12, 2011 Sep DISC >D> AB EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC >A> @ EQ 10MG BASE A 077771 003 Apr 12, 2011 Sep DISC >A> AB YILING EQ 2.5MG BASE A 076692 001 Jul 20, 2007 Sep CAHN >A> AB EQ 5MG BASE A 076692 002 Jul 20, 2007 Sep CAHN >A> AB EQ 10MG BASE A 076692 003 Jul 20, 2007 Sep CAHN AMOXICILLIN; CLAVULANATE POTASSIUM TABLET, EXTENDED RELEASE;ORAL AMOXICILLIN AND CLAVULANATE POTASSIUM >D> AB SANDOZ 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >A> AB ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CHRS >A> ! 1GM;EQ 62.5MG BASE A 090227 001 Apr 21, 2010 Sep CTEC >D> AUGMENTIN XR >D> AB +! NEOPHARMA 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC >A> + @ 1GM;EQ 62.5MG BASE N 050785 001 Sep 25, 2002 Sep DISC AMPHETAMINE SULFATE TABLET;ORAL AMPHETAMINE SULFATE >A> AA NOVAST LABS 5MG A 213763 001 Aug 24, 2020 Sep CAHN >A> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN >D> AA RICONPHARMA LLC 5MG A 213763 001 Aug 24, 2020 Sep CAHN >D> AA 10MG A 213763 002 Aug 24, 2020 Sep CAHN ANASTROZOLE TABLET;ORAL ANASTROZOLE >D> AB HIKMA 1MG A 078485 001 Jun 28, 2010 Sep DISC >A> @ 1MG A 078485 001 Jun 28, 2010 Sep DISC Page 2 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST APIXABAN TABLET;ORAL APIXABAN >A> AB INDOCO 2.5MG A 209898 001 Sep 11, 2020 Sep NEWA >A> AB 5MG A 209898 002 Sep 11, 2020 Sep NEWA ELIQUIS >D> + BRISTOL MYERS SQUIBB 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC >A> AB + 2.5MG N 202155 001 Dec 28, 2012 Sep CTEC >D> +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC >A> AB +! 5MG N 202155 002 Dec 28, 2012 Sep CTEC ASPIRIN; BUTALBITAL; CAFFEINE TABLET;ORAL BUTALBITAL, ASPIRIN AND CAFFEINE >D> AA ! HIKMA INTL PHARMS 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >A> @ 325MG;50MG;40MG A 086162 002 Feb 16, 1984 Sep DISC >D> AA STRIDES PHARMA 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS >A> AA ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CHRS >A> ! 325MG;50MG;40MG A 204195 001 Sep 22, 2016 Sep CTEC ATROPINE SULFATE SOLUTION;INTRAVENOUS ATROPINE SULFATE >A> +! ACCORD HLTHCARE 0.4MG/ML (0.4MG/ML) N 214652 001 Sep 29, 2020 Sep NEWA >A> +! 1MG/ML (1MG/ML) N 214652 002 Sep 29, 2020 Sep NEWA >D> +! HOSPIRA 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG >A> AA +! 1MG/10ML (0.1MG/ML) N 021146 005 Aug 17, 2017 Sep CFTG >A> AA INTL MEDICATION SYS 1MG/10ML (0.1MG/ML) A 212461 001 Oct 05, 2020 Sep NEWA ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE TABLET;ORAL DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE >A> AA SPECGX LLC 2.5MG;0.025MG A 213335 001 Oct 06, 2020 Sep NEWA LOMOTIL >D> AA +! GD SEARLE LLC 0.025MG;2.5MG N 012462 001 Sep 15, 1960 Sep CAHN >A> AA +! PFIZER 0.025MG;2.5MG N 012462 001 Sep 15, 1960 Sep CAHN AZACITIDINE >A> TABLET;ORAL >A> ONUREG >A> + CELGENE CORP 200MG N 214120 001 Sep 01, 2020 Sep NEWA >A> +! 300MG N 214120 002 Sep 01, 2020 Sep NEWA AZELAIC ACID AEROSOL, FOAM;TOPICAL >A> AZELAIC ACID >A> AB TEVA PHARMS USA 15% A 210928 001 Oct 07, 2020 Sep NFTG FINACEA >D> +! LEO PHARMA AS 15% N 207071 001 Jul 29, 2015 Sep CFTG >A> AB +! 15% N 207071 001 Jul 29, 2015 Sep CFTG BENAZEPRIL HYDROCHLORIDE TABLET;ORAL BENAZEPRIL HYDROCHLORIDE >A> AB ANNORA PHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN >A> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN >A> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN >A> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN >D> AB COREPHARMA 5MG A 077128 001 Mar 08, 2006 Sep CAHN >D> AB 10MG A 077128 002 Mar 08, 2006 Sep CAHN >D> AB 20MG A 077128 003 Mar 08, 2006 Sep CAHN >D> AB 40MG A 077128 004 Mar 08, 2006 Sep CAHN BETAMETHASONE DIPROPIONATE LOTION;TOPICAL BETAMETHASONE DIPROPIONATE >A> @ INVATECH EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN >D> @ PHARMADERM EQ 0.05% BASE A 070274 001 Aug 12, 1985 Sep CAHN Page 3 of 33 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE SUSPENSION;TOPICAL CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE >A> AB PERRIGO UK FINCO 0.064%;0.005% A 212367 001 Sep 11, 2020 Sep NEWA BETHANECHOL CHLORIDE TABLET;ORAL BETHANECHOL CHLORIDE >A> AA DISCOVERY THERAP 5MG A 040728 002 Oct 26, 2007 Sep CAHN >A> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >A> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >A> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN >D> AA ECI PHARMS LLC 5MG A 040728 002 Oct 26, 2007 Sep CAHN >D> AA 10MG A 040728 003 Oct 26, 2007 Sep CAHN >D> AA 25MG A 040728 004 Oct 26, 2007 Sep CAHN >D> AA 50MG A 040728 001 Oct 26, 2007 Sep CAHN BIVALIRUDIN INJECTABLE;INTRAVENOUS BIVALIRUDIN >D> AP CIPLA 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN >A> AP HONG KONG 250MG/VIAL A 091602 001 Jul 16, 2018 Sep CAHN BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE SYRUP;ORAL BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE >A> AA BRECKENRIDGE 2MG/5ML;10MG/5ML;30MG/5ML A 203997 001 Sep 30, 2020 Sep NEWA >A> AA EYWA 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN >D> AA WES PHARMA INC 2MG/5ML;10MG/5ML;30MG/5ML A 211170 001 Jun 16, 2020 Sep CAHN BUDESONIDE TABLET, EXTENDED RELEASE;ORAL BUDESONIDE >A> AB MYLAN 9MG A 208851 001 Sep 17, 2020 Sep NEWA BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL BUPROPION HYDROCHLORIDE >A> AB3 ADAPTIS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >A> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN >D> AB3 GRAVITI PHARMS 150MG A 211020 001 Jan 28, 2019 Sep CAHN >D> AB3 300MG A 211020 002 Jan 28, 2019 Sep CAHN CAFFEINE CITRATE SOLUTION;INTRAVENOUS CAFFEINE CITRATE >D> AP SUN PHARM EQ 30MG BASE/3ML (EQ 10MG A 090077 001 Sep 30, 2009 Sep DISC BASE/ML) >A> @ EQ 30MG BASE/3ML (EQ 10MG A 090077 001 Sep 30, 2009 Sep DISC BASE/ML) CAFFEINE; ERGOTAMINE TARTRATE